Literature DB >> 6978603

Interaction between alpha 1 antitrypsin and lymphocyte surface proteases: immunoregulatory effects.

J Bata, J P Revillard.   

Abstract

Alpha 1 antitrypsin (alpha 1-AT) is the major plasma protease inhibitor. Radioiodinated alpha 1-AT binds to human lymphocytes. The binding is fast and reversible, and the cells can be saturated with a maximum of approximately 1.2 x 10(6) molecules of alpha 1-AT per lymphocyte. The receptor for alpha 1-AT is a surface-associated protease. Addition of alpha 1-AT completely inhibits cell surface proteolytic activity. Furthermore alpha 1-AT decreases 3H-thymidine incorporation into lymphocytes stimulated by B or T cell mitogens or by allogeneic cells. Since alpha 1-AT was shown to be produced by activated monocytes and to bind to lymphocytes, it is likely to represent a mediator of monocyte-lymphocyte interactions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6978603     DOI: 10.1007/BF01978764

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  Distribution of cells binding erythrocyte-antibody (EA) complexes in human lymphoid populations.

Authors:  C Samarut; J Brochier; J P Revillard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Relationship between cell surface protease activity and doubling time in various normal and transformed cells.

Authors:  V B Hatcher; M S Wertheim; C Y Rhee; G Tsien; P G Burk
Journal:  Biochim Biophys Acta       Date:  1976-12-21

4.  Effect of protease inhibitors on mitogen stimulation of hamster lymphoid cells.

Authors:  D A Hart; J S Streilein
Journal:  Exp Cell Res       Date:  1976-10-15       Impact factor: 3.905

5.  Effects of the antiprotease Trasylol on peripheral blood leucocytes.

Authors:  A W Thomson; R G Pugh-Humphreys; D J Tweedie; C H Horne
Journal:  Experientia       Date:  1978-04-15

6.  Stimulation of mouse B lymphocytes by trypsin.

Authors:  T L Vischer
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

7.  Suppression of RNA synthesis in lymphocytes by inhibitors of proteolytic enzymes.

Authors:  Z Darzynkiewicz; B G Arnason
Journal:  Exp Cell Res       Date:  1974-03-30       Impact factor: 3.905

8.  Determination of subpopulations of leukocytes involved in the synthesis of alpha 1-antitrypsin in vitro.

Authors:  G B Wilson; J H Walker; J H Watkins; D Wolgroch
Journal:  Proc Soc Exp Biol Med       Date:  1980-05

9.  Inhibition of lymphocyte transformation: effect of soy bean trypsin inhibitor and synthetic anti-proteases.

Authors:  P Moreau; J Dornand; J G Kaplan
Journal:  Can J Biochem       Date:  1975-12

10.  Binding of alpha 1 antitrypsin (alpha 1 protease inhibitor) to human lymphocytes.

Authors:  J Bata; P Deviller; J P Revillard
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

View more
  5 in total

Review 1.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

2.  Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.

Authors:  H M Morrison; J A Kramps; J H Dijkman; R A Stockley
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

3.  Alpha-1 Antitrypsin Attenuates Acute Lung Allograft Injury in a Rat Lung Transplant Model.

Authors:  Amir M Emtiazjoo; Hanbo Hu; Li Lu; Mark L Brantly
Journal:  Transplant Direct       Date:  2019-05-29

Review 4.  Alpha-1-antitrypsin in cell and organ transplantation.

Authors:  Mel Berger; Mingyao Liu; Marc E Uknis; Maria Koulmanda
Journal:  Am J Transplant       Date:  2018-04-24       Impact factor: 8.086

5.  Renoprotective Effects of Alpha-1 Antitrypsin against Tacrolimus-Induced Renal Injury.

Authors:  Jeong-Hoon Lim; Eun-Joo Oh; Se-Hyun Oh; Hee-Yeon Jung; Ji-Young Choi; Jang-Hee Cho; Sun-Hee Park; Yong-Lim Kim; Chan-Duck Kim
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.